Cargando…
CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34a
Cancer is a complex disease process that evolves as a consequence of multiple malfunctions in key regulatory molecular networks. Understanding these networks will be essential to combat cancer. In this study, we focussed on central players in such networks. In a series of colon and breast cancer cel...
Autores principales: | Muppala, Santoshi, Mudduluru, Giridhar, Leupold, Jörg H., Buergy, Daniel, Sleeman, Jonathan P., Allgayer, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606220/ https://www.ncbi.nlm.nih.gov/pubmed/23533633 http://dx.doi.org/10.1371/journal.pone.0059563 |
Ejemplares similares
-
Correction: CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34a
Publicado: (2015) -
The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
por: Xiang, Ying, et al.
Publicado: (2020) -
Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance
por: Moreno-Mateos, Miguel A., et al.
Publicado: (2013) -
miR-21: an oncomir on strike in prostate cancer
por: Folini, Marco, et al.
Publicado: (2010) -
miR-24 in diabetes
por: Xiang, Yaozu
Publicado: (2015)